The knowledge management platform for clinicians, will use the funds raised to accelerate the rollout of its AI functionality.
Belfast-based Eolas Medical has raised $12 million (£8.9 million) Series A funding to accelerate the rollout of its AI functionality.
The round was led by German venture capital fund Acton Capital.
Founded in 2019, the firm says that it is already embedded in more than 400 UK clinical sites and used by 85% of NHS acute trusts.
“Eolas has always been about solving a very practical problem: giving healthcare professionals fast, reliable access to the knowledge they need, when they need it,” said founder and chief executive Declan Kelly.
“This is especially important in acute settings, where staff are under pressure to make decisions quickly and safely,” he added.
Eolas’ web and mobile app replaces intranets and document stores with a single, searchable database, giving clinicians instant access to approved local guidance, policies and medicines information up to ten times faster than traditional methods.
The firm provides a shared clinical playbook that moves with teams and supports decision-making wherever they work. Its AI-powered search allows staff to ask questions in plain language and receive results sourced directly from their organisation’s internal resources.
“Our conversations with clinicians showed remarkable enthusiasm for Eolas. Clinicians love the product. The benefit is immediate, the value is clear, and this conviction and their unique positioning in the market strongly shaped our excitement to partner with Eolas Medical,” said Fritz Oidtmann, managing partner at Acton Capital.
According to Crunchbase, Eolas previously raised undisclosed seed funding led by venture capital firm Samaipata in March 2021.
